Hatib, Bb Boy E.
HRN: 25-65-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/19/2025
04/26/2025
IV
380mg
Q6H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes